Global Premature Ejaculation Treatment Market Size, Share, Trends and Forecast 2022-2030

Common treatment options for premature ejaculation include behavioral techniques, topical anesthetics, medications and counseling. Keep in mind that it might take time to find the treatment or combination of treatments that will work for you. Behavioral treatment plus drug therapy might be the most effective course.
Industry Insights

The global Premature Ejaculation Treatment market size is projected to reach US$ 5341.1 million by 2028, from US$ 2864 million in 2021, at a CAGR of 9.2% during 2022-2028.

Global Premature Ejaculation Treatment key players include Pfizer, Novartis, Eli Lilly, Johnson & Johnson, etc.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Premature Ejaculation Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Premature Ejaculation Treatment market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Premature Ejaculation Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Premature Ejaculation Treatment market.

Impact of Covid-19 Outbreak

This section of the report has explored the overall status of the Covid scenario and has offered valuable insights into the changes in supply chain disruption, fluctuations in demand, etc. The analysts have also focused on the key measures that the companies are opting to withstand the harsh scenario.

Segmental Analysis

The report has been segmented into product and application segments. The researchers have documented all the products present today in the Premature Ejaculation Treatment market. They have also shed light on the new product innovations and launches by the key players. In the segmental analysis, the analysts have provided revenue forecast figures based on type and application for the period 2017-2028. They have also discussed about the growth rate and potential of each segment for the period 2017-2028.

Premature Ejaculation Treatment Breakdown Data by Type

Antidepressants(SSRIs)

Phosphodiesterase-5 Inhibitors

Topical Anesthetics

Analgesics

Other Treatment

Premature Ejaculation Treatment Breakdown Data by Distribution Channel

Hospital

Retail Pharmacy

Online Pharmacy

Other

Regional Analysis

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Competitive Landscape

This segment focuses on the key players operating in the industry. It underlines all the current and future activities by the prominent manufacturers. By understanding various initiatives being taken up by different players, readers will gain the ability to settle on correct business choices. The authors of the report have provided accurate revenue figures of the companies for the period 2017-2022. The clients are sure to gain the upper hand once they get hold of this report. Key players studied in the research report include:

Pfizer

Novartis

Eli Lilly

Johnson & Johnson

GlaxoSmithKline

Bayer

Menarini

Teva

Sunrise Pharma

Regent Pacific

Torrent Pharma

Vivus

1 Report Overview
1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Premature Ejaculation Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028

1.2.2 Antidepressants(SSRIs)

1.2.3 Phosphodiesterase-5 Inhibitors

1.2.4 Topical Anesthetics

1.2.5 Analgesics

1.2.6 Other Treatment

1.3 Market by Distribution Channel

1.3.1 Global Premature Ejaculation Treatment Market Share by Distribution Channel: 2017 VS 2021 VS 2028

1.3.2 Hospital

1.3.3 Retail Pharmacy

1.3.4 Online Pharmacy

1.3.5 Other

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global Premature Ejaculation Treatment Market Perspective (2017-2028)

2.2 Premature Ejaculation Treatment Growth Trends by Region

2.2.1 Premature Ejaculation Treatment Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Premature Ejaculation Treatment Historic Market Size by Region (2017-2022)

2.2.3 Premature Ejaculation Treatment Forecasted Market Size by Region (2023-2028)

2.3 Premature Ejaculation Treatment Market Dynamics

2.3.1 Premature Ejaculation Treatment Industry Trends

2.3.2 Premature Ejaculation Treatment Market Drivers

2.3.3 Premature Ejaculation Treatment Market Challenges

2.3.4 Premature Ejaculation Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Premature Ejaculation Treatment Players by Revenue

3.1.1 Global Top Premature Ejaculation Treatment Players by Revenue (2017-2022)

3.1.2 Global Premature Ejaculation Treatment Revenue Market Share by Players (2017-2022)

3.2 Global Premature Ejaculation Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Premature Ejaculation Treatment Revenue

3.4 Global Premature Ejaculation Treatment Market Concentration Ratio

3.4.1 Global Premature Ejaculation Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Premature Ejaculation Treatment Revenue in 2021

3.5 Premature Ejaculation Treatment Key Players Head office and Area Served

3.6 Key Players Premature Ejaculation Treatment Product Solution and Service

3.7 Date of Enter into Premature Ejaculation Treatment Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Premature Ejaculation Treatment Breakdown Data by Type

4.1 Global Premature Ejaculation Treatment Historic Market Size by Type (2017-2022)

4.2 Global Premature Ejaculation Treatment Forecasted Market Size by Type (2023-2028)

5 Premature Ejaculation Treatment Breakdown Data by Distribution Channel

5.1 Global Premature Ejaculation Treatment Historic Market Size by Distribution Channel (2017-2022)

5.2 Global Premature Ejaculation Treatment Forecasted Market Size by Distribution Channel (2023-2028)

6 North America

6.1 North America Premature Ejaculation Treatment Market Size (2017-2028)

6.2 North America Premature Ejaculation Treatment Market Size by Country (2017-2022)

6.3 North America Premature Ejaculation Treatment Market Size by Country (2023-2028)

6.4 United States

6.5 Canada

7 Europe

7.1 Europe Premature Ejaculation Treatment Market Size (2017-2028)

7.2 Europe Premature Ejaculation Treatment Market Size by Country (2017-2022)

7.3 Europe Premature Ejaculation Treatment Market Size by Country (2023-2028)

7.4 Germany

7.5 France

7.6 U.K.

7.7 Italy

7.8 Russia

7.9 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Premature Ejaculation Treatment Market Size (2017-2028)

8.2 Asia-Pacific Premature Ejaculation Treatment Market Size by Country (2017-2022)

8.3 Asia-Pacific Premature Ejaculation Treatment Market Size by Country (2023-2028)

8.4 China

8.5 Japan

8.6 South Korea

8.7 Southeast Asia

8.8 India

8.9 Australia

9 Latin America

9.1 Latin America Premature Ejaculation Treatment Market Size (2017-2028)

9.2 Latin America Premature Ejaculation Treatment Market Size by Country (2017-2022)

9.3 Latin America Premature Ejaculation Treatment Market Size by Country (2023-2028)

9.4 Mexico

9.5 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Premature Ejaculation Treatment Market Size (2017-2028)

10.2 Middle East & Africa Premature Ejaculation Treatment Market Size by Country (2017-2022)

10.3 Middle East & Africa Premature Ejaculation Treatment Market Size by Country (2023-2028)

10.4 Turkey

10.5 Saudi Arabia

10.6 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Detail

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Premature Ejaculation Treatment Introduction

11.1.4 Pfizer Revenue in Premature Ejaculation Treatment Business (2017-2022)

11.1.5 Pfizer Recent Development

11.2 Novartis

11.2.1 Novartis Company Detail

11.2.2 Novartis Business Overview

11.2.3 Novartis Premature Ejaculation Treatment Introduction

11.2.4 Novartis Revenue in Premature Ejaculation Treatment Business (2017-2022)

11.2.5 Novartis Recent Development

11.3 Eli Lilly

11.3.1 Eli Lilly Company Detail

11.3.2 Eli Lilly Business Overview

11.3.3 Eli Lilly Premature Ejaculation Treatment Introduction

11.3.4 Eli Lilly Revenue in Premature Ejaculation Treatment Business (2017-2022)

11.3.5 Eli Lilly Recent Development

11.4 Johnson & Johnson

11.4.1 Johnson & Johnson Company Detail

11.4.2 Johnson & Johnson Business Overview

11.4.3 Johnson & Johnson Premature Ejaculation Treatment Introduction

11.4.4 Johnson & Johnson Revenue in Premature Ejaculation Treatment Business (2017-2022)

11.4.5 Johnson & Johnson Recent Development

11.5 GlaxoSmithKline

11.5.1 GlaxoSmithKline Company Detail

11.5.2 GlaxoSmithKline Business Overview

11.5.3 GlaxoSmithKline Premature Ejaculation Treatment Introduction

11.5.4 GlaxoSmithKline Revenue in Premature Ejaculation Treatment Business (2017-2022)

11.5.5 GlaxoSmithKline Recent Development

11.6 Bayer

11.6.1 Bayer Company Detail

11.6.2 Bayer Business Overview

11.6.3 Bayer Premature Ejaculation Treatment Introduction

11.6.4 Bayer Revenue in Premature Ejaculation Treatment Business (2017-2022)

11.6.5 Bayer Recent Development

11.7 Menarini

11.7.1 Menarini Company Detail

11.7.2 Menarini Business Overview

11.7.3 Menarini Premature Ejaculation Treatment Introduction

11.7.4 Menarini Revenue in Premature Ejaculation Treatment Business (2017-2022)

11.7.5 Menarini Recent Development

11.8 Teva

11.8.1 Teva Company Detail

11.8.2 Teva Business Overview

11.8.3 Teva Premature Ejaculation Treatment Introduction

11.8.4 Teva Revenue in Premature Ejaculation Treatment Business (2017-2022)

11.8.5 Teva Recent Development

11.9 Sunrise Pharma

11.9.1 Sunrise Pharma Company Detail

11.9.2 Sunrise Pharma Business Overview

11.9.3 Sunrise Pharma Premature Ejaculation Treatment Introduction

11.9.4 Sunrise Pharma Revenue in Premature Ejaculation Treatment Business (2017-2022)

11.9.5 Sunrise Pharma Recent Development

11.10 Regent Pacific

11.10.1 Regent Pacific Company Detail

11.10.2 Regent Pacific Business Overview

11.10.3 Regent Pacific Premature Ejaculation Treatment Introduction

11.10.4 Regent Pacific Revenue in Premature Ejaculation Treatment Business (2017-2022)

11.10.5 Regent Pacific Recent Development

11.11 Torrent Pharma

11.11.1 Torrent Pharma Company Detail

11.11.2 Torrent Pharma Business Overview

11.11.3 Torrent Pharma Premature Ejaculation Treatment Introduction

11.11.4 Torrent Pharma Revenue in Premature Ejaculation Treatment Business (2017-2022)

11.11.5 Torrent Pharma Recent Development

11.12 Vivus

11.12.1 Vivus Company Detail

11.12.2 Vivus Business Overview

11.12.3 Vivus Premature Ejaculation Treatment Introduction

11.12.4 Vivus Revenue in Premature Ejaculation Treatment Business (2017-2022)

11.12.5 Vivus Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details